Optometrists in Woodruff, WI Accepting Medicare

6 Optometrists found. Showing 1 - 6

Benjamin K Redman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1020 3rd Ave, Woodruff, WI 54568 Phone: 715-356-2262    Fax: 715-356-2257

Buffington Optometry Llc Optometrist Medicare: Medicare Enrolled Practice Location: 706 Elm St., Woodruff, WI 54568 Phone: 715-358-4060    Fax: 715-358-2561

Dr. Kathleen Erin Buffington, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 706 Elm St., Woodruff, WI 54568 Phone: 715-358-4060    Fax: 715-358-2561

Jill C Redman, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1020 3rd Ave, Woodruff, WI 54568 Phone: 715-356-2262    Fax: 715-356-2257

Redman & Gelinas Sc Optometrist Medicare: Medicare Enrolled Practice Location: 1020 3rd Ave, Woodruff, WI 54568 Phone: 715-356-2262    Fax: 715-356-2257

Kirby D Redman, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1020 3rd Ave, Woodruff, WI 54568 Phone: 715-356-2262    Fax: 715-356-2257

News Archive

New mechanism that contributes to the development of some breast and ovarian cancers

Researchers at Mount Sinai School of Medicine have discovered a new mechanism of activation of a pathway known to be implicated in many cancers.

Longer looks: Phenomenal growth of the Cleveland Clinic prompts hopes for the city; the bittersweet decision to donate organs

Delos M. "Toby" Cosgrove arrived at the Cleveland Clinic in 1975 as an "incredibly poor" 34-year-old dreaming of a life as a cardiac surgeon. … As the years passed he became well-known for pioneering the replacement of heart valves, eventually assuming the chair of the department of cardiothoracic surgery.

Daiichi Sankyo files NDA for development and marketing of Methylene Blue medicinal product in Japan

Provepharm, a French company specialized in the development of pharmaceutical applications, today announces that Daiichi Sankyo, Co. Ltd., a global pharmaceutical firm, has filed an NDA (New Drug Application) for the development and marketing of the injectable Methylene Blue medicinal product in Japan, made out of Provepharm's Proveblue Methylene Blue active substance.

Study: Bereaved individuals face higher risk of dying from melanoma

Individuals who experience the loss of a partner are less likely to be diagnosed with melanoma but face an increased risk of dying from the disease, according to research published in the British Journal of Dermatology.

Wildlife Conservation Society to monitor diseases for preventing global pandemic

The Wildlife Conservation Society will play a key role in a new international effort to monitor diseases that move between animals and people in order to prevent the next global pandemic.

Read more Medical News

› Verified 3 days ago